Kallikrein Cleaves C3 and Activates Complement.

Abstract:

The human plasma contact system is an immune surveillance system activated by the negatively charged surfaces of bacteria and fungi and includes the kallikrein-kinin, the coagulation, and the fibrinolytic systems. Previous work shows that the contact system also activates complement, and that plasma enzymes like kallikrein, plasmin, thrombin, and FXII are involved in the activation process. Here, we show for the first time that kallikrein cleaves the central complement component C3 directly to yield active components C3b and C3a. The cleavage site within C3 is identical to that recognized by the C3 convertase. Also, kallikrein-generated C3b forms C3 convertases, which trigger the C3 amplification loop. Since kallikrein also cleaves factor B to yield Bb and Ba, kallikrein alone can trigger complement activation. Kallikrein-generated C3 convertases are inhibited by factor H; thus, the kallikrein activation pathway merges with the amplification loop of the alternative pathway. Taken together, these data suggest that activation of the contact system locally enhances complement activation on cell surfaces. The human pathogenic microbe Candida albicans activates the contact system in normal human serum. However, C. albicans immediately recruits factor H to the surface, thereby evading the alternative and likely kallikrein-mediated complement pathways.

SEEK ID: https://funginet.hki-jena.de/publications/179

PubMed ID: 29237166

Projects: C4 (E)

Journal: J Innate Immun

Citation: J Innate Immun. 2018;10(2):94-105. doi: 10.1159/000484257. Epub 2017 Dec 14.

Date Published: 14th Dec 2017

Authors: Sarah Irmscher, N. Doring, Luke Donald Halder, E. A. H. Jo, I. Kopka, C. Dunker, Ilse Jacobsen, S. Luo, Hortense Slevogt, S. Lorkowski, Niklas Beyersdorf, Peter Zipfel, Christine Skerka

Help
help Creator
Activity

Views: 115

Created: 18th Feb 2021 at 11:47

help Attributions

None

Related items

Powered by
(v.1.9.1)
Copyright © 2008 - 2019 The University of Manchester and HITS gGmbH